Artelo Biosciences, Inc. Share Price

Artelo Biosciences, Inc. Share Price

NASDAQ: ARTL | Micro Cap
$2.38
+$0.19 (8.68%) Last updated on 29 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Artelo Biosciences, Inc. Stock Performance

Open
$2.28
Prev. Close
$2.19
Circuit Range
N/A
Day Range
$2.27 - $2.28
Year Range
$0.62 - $19.60
Volume
492
Average Traded
$2.28

Artelo Biosciences, Inc. Share Price Today

As of 31 October 2026, Artelo Biosciences, Inc.'s share price is $2.38. The stock opened at $2.28, compared to its previous close of $2.19. During today's trading session, Artelo Biosciences, Inc.'s share price traded between $2.27 and $2.28, with an average price of $2.27. Over the past 52 weeks, the stock has recorded a high of $19.60 and a low of $0.62. In terms of performance, Artelo Biosciences, Inc.'s share price has declined by 28.74% over the last six months and is down 22.73% on a year-on-year basis.

Artelo Biosciences, Inc. Share Price Chart

Line chart of the Artelo Biosciences, Inc. price trend over the selected period. The price rose overall, ranging from 2.27 to 2.29, ending at 2.29.
$2.27$2.28
L
Show Current Price
H

Artelo Biosciences, Inc. Stock Fundamentals & Key Indicators

Market Cap
$2.45M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-23.13
Revenue (TTM)
$0.00
Return On Equity (TTM)
-253.57%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
22.12%

Artelo Biosciences, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$3.12-$4.17-$2.96-$2.43
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-33.65%29.02%17.91%

Artelo Biosciences, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$10.08-$9.29-$9.83-$12.88
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A7.84%-5.81%-31.03%

About Artelo Biosciences, Inc.

Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.

Artelo Biosciences, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$3.93
$2.27
-44.07%
Sep 2026
$5.89
$4.06
+511.30%
Aug 2026
$0.76
$0.66
-16.48%
Jul 2026
$1.09
$0.80
-29.33%
Jun 2026
$1.33
$1.13
-21.33%
May 2026
$3.41
$1.43
-57.19%
Apr 2026
$7.21
$3.34
-56.05%
Mar 2026
$1.13
$7.60
+533.33%
Feb 2026
$1.63
$1.20
-28.57%
Jan 2026
$1.29
$1.68
+38.84%
Dec 2025
$1.64
$1.21
-31.25%
Nov 2025
$3.07
$1.76
-42.86%

ARTL Share Price FAQs